Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and Synthesis

ACS Medicinal Chemistry Letters

Volumn 7, Issue 1, 2016, Pages 56-61

  Badavath, Vishnu Nayak ^a   Baysal, Ipek ^b   Ucar, Gulberk ^b   Sinha, Barij Nayan ^a   Jayaprakash, Venkatesan ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY   (India)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

enzyme inhibitors; Human monoamine oxidase; molecular docking simulation; pyrazoline

Indexed keywords

CURCUMIN; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PYRAZOLINE DERIVATIVE;

ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; ISOMER; MOLECULAR DOCKING; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SELECTIVITY INDEX;

EID: 84955480132     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/acsmedchemlett.5b00326     Document Type: Article

References (29)

1. YOUDIM, M. B. H.; COLLINS, G. G. S.; SANDLER, M.; JONES, A. B. B.; PARE, C. M. B.; NICHOLSON, W. J. Biological Sciences: Human Brain Monoamine Oxidase: Multiple Forms and Selective Inhibitors Nature 1972, 236 (5344) 225-228 10.1038/236225b0
2. Collins, G. G. S.; Sandler, M.; Williams, E. D.; Youdim, M. B. H. Multiple Forms of Human Brain Mitochondrial Monoamine Oxidase Nature 1970, 225 (5235) 817-820 10.1038/225817a0
3. Johnston, J. P. Some Observations Upon a New Inhibitor of Monoamine Oxidase in Brain Tissue Biochem. Pharmacol. 1968, 17, 1285-1297 10.1016/0006-2952(68)90066-X
4. Knoll, J.; Magyar, K. Some Puzzling Pharmacological Effects of Monoamine Oxidase Inhibitors Adv. Biochem. Psychopharmacol. 1971, 5, 393-408
5. OCarroll, A. M.; Fowler, C. J.; Phillips, J. P.; Tobbia, I.; Tipton, K. F. The Deamination of Dopamine by Human Brain Monoamine Oxidase-Specificity for the Two Enzyme Forms in Seven Brain Regions Naunyn-Schmiedeberg's Arch. Pharmacol. 1983, 322, 198-202 10.1007/BF00500765
6. Da Prada, M.; Keller, H. H.; Kettler, R. Comparison of the New MAO-A Inhibitors Moclobemide, Brofaromine and Toloxatone with Tranylcypromine in an Animal Experiment: Significance for Clinical Practice Psychiatr. Prax. 1989, 16 (Suppl 1) 18-24
7. Lavian, G.; Finberg, J. P.; Youdim, M. B. The Advent of a New Generation of Monoamine Oxidase Inhibitor Antidepressants: Pharmacologic Studies with Moclobemide and Brofaromine Clin. Neuropharmacol. 1993, 16 (Suppl 2) S1-S7
8. Youdim, M. B. H.; Weinstock, M. Therapeutic Applications of Selective and Non-Selective Inhibitors of Monoamine Oxidase A and B That Do Not Cause Significant Tyramine Potentiation NeuroToxicology 2004, 25, 243-250 10.1016/S0161-813X(03)00103-7
9. Xu, Y.; Ku, B. S.; Yao, H. Y.; Lin, Y. H.; Ma, X.; Zhang, Y. H.; Li, X. J. Antidepressant Effects of Curcumin in the Forced Swim Test and Olfactory Bulbectomy Models of Depression in Rats Pharmacol., Biochem. Behav. 2005, 82, 200-206 10.1016/j.pbb.2005.08.009
10. Kulkarni, S. K.; Bhutani, M. K. Antidepressant Activity of Curcumin: Involvement of Serotonin and Dopamine System Psychopharmacology 2008, 201, 435-442 10.1007/s00213-008-1300-y
11. Rajeswari, A.; Sabesan, M. Inhibition of Monoamine Oxidase-B by the Polyphonic Compound, Curcumin and Its Metabolite Tetrahydrocurcumin, in a Model of Parkinsons Disease Induced by MPTP Neurodegenration in Mice. Inflammopharmacology 2008, 16, 96-99 10.1007/s10787-007-1614-0
12. Zhang, L.; Luo, J.; Zhang, M.; Yao, W.; Ma, X.; Yu, S. Y. Effects of Curcumin on Chronic, Unpredictable, Mild, Stress-Induced Depressive-like Behaviour and Structural Plasticity in the Lateral Amygdala of Rats Int. J. Neuropsychopharmacol. 2014, 17, 793-806 10.1017/S1461145713001661
13. Wang, R.; Xu, Y.; Wu, H. L.; Li, Y. B.; Li, Y. H.; Guo, J. B.; Li, X. J. The Antidepressant Effects of Curcumin in the Forced Swimming Test Involve 5-HT1 and 5-HT2 Receptors Eur. J. Pharmacol. 2008, 578, 43-50 10.1016/j.ejphar.2007.08.045
14. Xu, Y.; Ku, B. S.; Yao, H. Y.; Lin, Y. H.; Ma, X.; Zhang, Y. H.; Li, X. J. The Effects of Curcumin on Depressive-like Behaviors in Mice Eur. J. Pharmacol. 2005, 518, 40-46 10.1016/j.ejphar.2005.06.002
15. Vishnu Nayak, B.; Ciftci-Yabanoglu, S.; Jadav, S. S.; Jagrat, M.; Sinha, B. N.; Ucar, G.; Jayaprakash, V. Monoamine Oxidase Inhibitory Activity of 3,5-Biaryl-4,5-Dihydro-1H-Pyrazole-1-Carboxylate Derivatives Eur. J. Med. Chem. 2013, 69, 762-767 10.1016/j.ejmech.2013.09.010
16. Sahoo, A.; Yabanoglu, S.; Sinha, B. N.; Ucar, G.; Basu, A.; Jayaprakash, V. Towards Development of Selective and Reversible Pyrazoline Based MAO-Inhibitors: Synthesis, Biological Evaluation and Docking Studies Bioorg. Med. Chem. Lett. 2010, 20 (1) 132-136 10.1016/j.bmcl.2009.11.015
17. Jagrat, M.; Behera, J.; Yabanoglu, S.; Ercan, A.; Ucar, G.; Sinha, B. N.; Sankaran, V.; Basu, A.; Jayaprakash, V. Pyrazoline Based MAO Inhibitors: Synthesis, Biological Evaluation and SAR Studies Bioorg. Med. Chem. Lett. 2011, 21 (14) 4296-4300 10.1016/j.bmcl.2011.05.057
18. Ozdemir, Z.; Kandilci, H. B.; Gumusel, B.; Calis, U.; Bilgin, a A. Synthesis and Studies on Antidepressant and Anticonvulsant Activities of Some 3-(2-Furyl)-Pyrazoline Derivatives Eur. J. Med. Chem. 2007, 42 (3) 373-379 10.1016/j.ejmech.2006.09.006
19. Nepali, K.; Singh, G.; Turan, A.; Agarwal, A.; Sapra, S.; Kumar, R.; Banerjee, U. C.; Verma, P. K.; Satti, N. K.; Gupta, M. K.; Suri, O. P.; Dhar, K. L. A Rational Approach for the Design and Synthesis of 1-Acetyl-3,5-Diaryl-4,5-dihydro(1H)pyrazoles as a New Class of Potential Non-Purine Xanthine Oxidase Inhibitors Bioorg. Med. Chem. 2011, 19, 1950-1958 10.1016/j.bmc.2011.01.058
20. Chimenti, F.; Maccioni, E.; Secci, D.; Bolasco, A.; Chimenti, P.; Granese, A.; Carradori, S.; Alcaro, S.; Ortuso, F.; Yáñez, M.; Orallo, F.; Cirilli, R.; Ferretti, R.; La Torre, F. Synthesis, Stereochemical Identification, and Selective Inhibitory Activity against Human Monoamine Oxidase-B of 2-Methylcyclohexylidene-(4-Arylthiazol-2- Yl)hydrazones J. Med. Chem. 2008, 51, 4874-4880 10.1021/jm800132g
21. Yáñez, M.; Fraiz, N.; Cano, E.; Orallo, F. Inhibitory Effects of Cis- and Trans-Resveratrol on Noradrenaline and 5-Hydroxytryptamine Uptake and on Monoamine Oxidase Activity Biochem. Biophys. Res. Commun. 2006, 344 (2) 688-695 10.1016/j.bbrc.2006.03.190
22. Bradford, M. M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding Anal. Biochem. 1976, 72, 248-254 10.1016/0003-2697(76)90527-3
23. Chimenti, F.; Carradori, S.; Secci, D.; Bolasco, A.; Bizzarri, B.; Chimenti, P.; Granese, A.; Yáñez, M.; Orallo, F. Synthesis and Inhibitory Activity against Human Monoamine Oxidase of N1-Thiocarbamoyl-3,5-Di(hetero)aryl-4,5-Dihydro-(1H)-Pyrazole Derivatives Eur. J. Med. Chem. 2010, 45, 800-804 10.1016/j.ejmech.2009.11.003
24. Youdim, M. B. H.; Bakhle, Y. S. Monoamine Oxidase: Isoforms and Inhibitors in Parkinsons Disease and Depressive Illness Br. J. Pharmacol. 2006, 147 (S1) S287-S296 10.1038/sj.bjp.0706464
25. Secci, D.; Bolasco, A.; Chimenti, P.; Carradori, S. The State of the Art of Pyrazole Derivatives as Monoamine Oxidase Inhibitors and Antidepressant/anticonvulsant Agents Curr. Med. Chem. 2011, 18 (33) 5114-5144 10.2174/092986711797636090
26. Secci, D.; Carradori, S.; Bolasco, A.; Bizzarri, B.; DAscenzio, M.; Maccioni, E. Discovery and Optimization of Pyrazoline Derivatives as Promising Monoamine Oxidase Inhibitors Curr. Top. Med. Chem. 2012, 12 (20) 2240-2257 10.2174/156802612805220057
27. Chimenti, F.; Fioravanti, R.; Bolasco, A.; Manna, F.; Chimenti, P.; Secci, D.; Rossi, F.; Turini, P.; Ortuso, F.; Alcaro, S.; Cardia, M. C. Synthesis, Molecular Modeling Studies and Selective Inhibitory Activity against MAO of N1-Propanoyl-3,5-Diphenyl-4,5-Dihydro-(1H)-Pyrazole Derivatives Eur. J. Med. Chem. 2008, 43 (10) 2262-2267 10.1016/j.ejmech.2007.12.026
28. Chimenti, F.; Bolasco, A.; Secci, D.; Chimenti, P.; Granese, A.; Carradori, S.; Yáñez, M.; Orallo, F.; Ortuso, F.; Alcaro, S. Investigations on the 2-Thiazolylhydrazyne Scaffold: Synthesis and Molecular Modeling of Selective Human Monoamine Oxidase Inhibitors Bioorg. Med. Chem. 2010, 18, 5715-5723 10.1016/j.bmc.2010.06.007
29. Desideri, N.; Bolasco, A.; Fioravanti, R.; Proietti Monaco, L.; Orallo, F.; Yáñez, M.; Ortuso, F.; Alcaro, S. Homoisoflavonoids: Natural Scaffolds with Potent and Selective Monoamine Oxidase-B Inhibition Properties J. Med. Chem. 2011, 54, 2155-2164 10.1021/jm1013709